Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 6, 2022
Distillery Therapeutics

Inhibiting KDM4B for alveolar rhabdomyosarcoma

BioCentury | Apr 1, 2022
Distillery Therapeutics

Degrading FOXO1 via KIND2 inhibition for NAFLD

BioCentury | Nov 6, 2018
Distillery Techniques

Drug delivery

BioCentury | Jul 25, 2018
Distillery Techniques

Disease models

BioCentury | Jul 11, 2018
Translation in Brief

The RNA Renaissance continues

How Disney’s Scripps lab has expanded the RNA target universe
BioCentury | Jun 5, 2018
Distillery Therapeutics

Cancer

BioCentury | Nov 30, 2017
Translation in Brief

Two faces of FOXO1

Columbia and AZ create new class of FOXO1 inhibitor
BioCentury | Oct 26, 2017
Translation in Brief

Transient nanotargeting

mRNA-loaded nanoparticles transiently modify therapeutic cells simply and safely
BioCentury | Oct 24, 2017
Distillery Techniques

Drug delivery; drug platforms

Items per page:
1 - 10 of 22